Metizoline
Chemical compound
- R01AA10 (WHO)
- 2-[(2-methyl-1-benzothien-3-yl)methyl]-4,5-dihydro-1H-imidazole
- 17692-22-7 Y
- 28688
- 26683 N
- Z27L8N105U
- D05006 N
- DTXSID9074983
- Interactive image
- CC1=C(C2=CC=CC=C2S1)CC3=NCCN3
InChI
- InChI=1S/C13H14N2S/c1-9-11(8-13-14-6-7-15-13)10-4-2-3-5-12(10)16-9/h2-5H,6-8H2,1H3,(H,14,15) N
- Key:NDNKHWUXXOFHTD-UHFFFAOYSA-N N
Metizoline (trade name Ellsyl) is a nasal decongestant against allergic and vasomotor rhinitis.[1]
References
- ^ Zumpft CW (January 1975). "Double-blind comparison of metizoline hydrochloride (Ellsyl) and phenylephrine in allergic and vasomotor rhinitis". Current Therapeutic Research, Clinical and Experimental. 17 (1): 40–6. PMID 49255.
- v
- t
- e
Decongestants and other nasal preparations (R01)
Sympathomimetics, plain | |
---|---|
Antiallergic agents, excluding corticosteroids | |
Corticosteroids | |
Other nasal preparations | |
Combination products |
Sympathomimetics
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e